Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             23 results found
no title author magazine year volume issue page(s) type
1 Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1α in Ehrlich ascites tumor cells Kumar, Akhilesh
2009
64 6 p. 1221-1233
article
2 Antineoplastic activity of idazoxan hydrochloride Eilon, G. F.
2009
64 6 p. 1157-1163
article
3 A phase II study of S-1 monotherapy as second-line treatment for advanced non-small cell lung cancer Totani, Yoshitaka
2009
64 6 p. 1181-1185
article
4 A phase I study of palliative chemoradiation therapy with paclitaxel and cisplatin for local symptoms due to an unresectable primary advanced or locally recurrent gastric adenocarcinoma Yoshikawa, Takaki
2009
64 6 p. 1071-1077
article
5 A randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033 in patients with pretreated metastatic breast cancer Rixe, Olivier
2009
64 6 p. 1139-1148
article
6 Endurance exercise training preserves cardiac function in rats receiving doxorubicin and the HER-2 inhibitor GW2974 Wonders, Karen Y.
2009
64 6 p. 1105-1113
article
7 Enhancement of cisplatin cytotoxicity by SAHA involves endoplasmic reticulum stress-mediated apoptosis in oral squamous cell carcinoma cells Suzuki, Maiko
2009
64 6 p. 1115-1122
article
8 Erlotinib in advanced non-small-cell lung cancer after gefitinib failure Zhou, Zheng-Tao
2009
64 6 p. 1123-1127
article
9 Experimental study of combination therapy with S-1 against pancreatic cancer Yoshizawa, Jun
2009
64 6 p. 1211-1219
article
10 Expression of Na,K-ATPase-β1 subunit increases uptake and sensitizes carcinoma cells to oxaliplatin Tummala, Ramakumar
2009
64 6 p. 1187-1194
article
11 In vitro assessment of novel transcription inhibitors and topoisomerase poisons in rhabdomyosarcoma cell lines Wolf, Steven J.
2009
64 6 p. 1059-1069
article
12 Outcome of upfront combination chemotherapy followed by chemoradiation for locally advanced pancreatic adenocarcinoma Reni, Michele
2009
64 6 p. 1253-1259
article
13 Panaxadiol, a purified ginseng component, enhances the anti-cancer effects of 5-fluorouracil in human colorectal cancer cells Li, Xiao-Li
2009
64 6 p. 1097-1104
article
14 Pharmacokinetics and metabolism of the putative cancer chemopreventive agent cyanidin-3-glucoside in mice Marczylo, Timothy H.
2009
64 6 p. 1261-1268
article
15 Phase I, dose escalation and pharmacokinetic study of cediranib (RECENTIN™), a highly potent and selective VEGFR signaling inhibitor, in Japanese patients with advanced solid tumors Yamamoto, Noboru
2009
64 6 p. 1165-1172
article
16 Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer Ch’ang, Hui-Ju
2009
64 6 p. 1173-1179
article
17 Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium Study Shibata, Stephen I.
2009
64 6 p. 1149-1155
article
18 Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy Musende, Alain G.
2009
64 6 p. 1085-1095
article
19 Preliminary results of M-VAC chemotherapy combined with mild hyperthermia, a new therapeutic strategy for advanced or metastatic transitional cell carcinoma of the urothelium Yamada, Yoshiaki
2009
64 6 p. 1079-1083
article
20 Pyrrolotetrazinones deazaanalogues of temozolomide induce apoptosis in Jurkat cell line: involvement of tubulin polymerization inhibition Viola, Giampietro
2009
64 6 p. 1235-1251
article
21 Schedule-dependent synergism and antagonism between pemetrexed and docetaxel in human lung cancer cell lines in vitro Kano, Yasuhiko
2009
64 6 p. 1129-1137
article
22 Thalidomide suppressed the growth of 4T1 cells into solid tumors in Balb/c mice in a combination therapy with the oncolytic fusogenic HSV-1 OncdSyn Israyelyan, Anna
2009
64 6 p. 1201-1210
article
23 Thymidylate synthetase allelic imbalance in clear cell renal carcinoma Colavito, Davide
2009
64 6 p. 1195-1200
article
                             23 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands